Clinical Trial Update: To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing efficacy (immunogenicity) and safety of the Euvichol rotavirus vaccine in healthy adults and children; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Euvichol (Rotavirus vaccine, live attenuated)

Snippet

Sponsor: EuBiologics Co.,Ltd | Conditions: Prevention Harmful Effects | Phase 3 | Status: COMPLETED